PlexinD1 is a driver and a therapeutic target in advanced prostate cancer.
Saved in:
| Title: | PlexinD1 is a driver and a therapeutic target in advanced prostate cancer. |
|---|---|
| Authors: | Wei J; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA., Wang J; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA. jing_wang1@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. jing_wang1@dfci.harvard.edu., Guan W; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA., Li J; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA.; Engineering Research Center of Cell & Therapeutic Antibody, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Pu T; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Corey E; Department of Urology, University of Washington, Seattle, WA, 98195, USA., Lin TP; Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan, 11217, Republic of China.; Department of Urology, School of Medicine and Shu-Tien Urological Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, 11221, Republic of China., Gao AC; Department of Urologic Surgery, University of California, Davis, Sacramento, CA, 95817, USA., Wu BJ; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA. boyang.wu@wsu.edu. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2025 Feb; Vol. 17 (2), pp. 336-364. Date of Electronic Publication: 2025 Jan 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1757-4684 |
|---|---|
| DOI: | 10.1038/s44321-024-00186-z |
